Home » Authors » Catherine Shaffer

Articles by Catherine Shaffer

NewCo News: Del Mar Pharma Bets on Glioblastoma Salvage Therapy

Aug. 17, 2010

By Catherine Shaffer

CeNeRx Hits Phase II Home Stretch with $13M Series C

Aug. 16, 2010

By Catherine Shaffer

NewCo News: Valocor says 'Beat It' to Acne, Atopic Dermatitis and Vitiligo

Aug. 13, 2010

By Catherine Shaffer

Dicerna Raises $25M Series B to Fund RNAi Cancer Program

Aug. 12, 2010

By Catherine Shaffer

Tetralogic Coasts into Clinic with $32M Financing

Aug. 11, 2010

By Catherine Shaffer

NewCo News: Sirnaomics Takes Multitarget Approach to Gene Silencing

Aug. 10, 2010

By Catherine Shaffer

Trius' IPO Low Like Others, but Window Could Be Near

Aug. 9, 2010

By Catherine Shaffer

NewCo News: Senex Targets Aging Diseases with CKI Pathway Inhibitors

Aug. 6, 2010

By Catherine Shaffer

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for May 26, 2026.
Sangamo presents primate data for prion suppressor ST-506
BioWorld Science
Sangamo Therapeutics Inc. discussed gene regulation approaches for neurodegenerative diseases when presenting findings on their clinical candidate ST-506 for the...
TREM2 agonists detailed in Pfizer patent
BioWorld Science
Pfizer Inc. has reported new triggering receptor expressed on myeloid cells 2 (TREM2) agonists potentially useful for the treatment of neurodegeneration.
News in brief
BioWorld Asia
BioWorld Asia briefs for May 26, 2026
Dual-targeting, rapamycin-enhanced CAR T for multiple myeloma
BioWorld Science
Umoja Biopharma Inc. performed preclinical studies to evaluate the antitumor activity of UB-VV500, an off-the-shell lentiviral vector CAR T-cell product. It is...